Likewise, the up-regulated Rasl10b gene encoding a small GTPase with tumour suppressor potential (Zou et al, 2006), which was shown to regulate blood flow in the atrium (Rybkin et al, 2007), could also participate in the antitumoral response downstream of oxaliplatin. This evidence concerns the gene RASL10B and neoplasm.